Investing.com UK - Financial Markets Worldwide
Get 50% Off
🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

Nike Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Published 21/12/2023, 15:59
© Reuters. Nike Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
NKE
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

NIKE, Inc. (NYSE: NKE) is projected to release financial results for its second quarter, after the closing bell on Dec. 21, 2023.

Analysts expect the company to post quarterly earnings at 84 cents per share, compared to year-ago earnings of 85 cents per share. The company’s revenue might come in at $13.43 billion for the latest quarter, according to Benzinga Pro.

Nike's board, last month, approved a quarterly cash dividend of 37 cents per share, representing a 9% increase compared to the company's prior quarterly dividend of 34 cents per share.

NIKE shares fell 1% to close at $121.43 on Wednesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.

  • Raymond James analyst Rick Patel maintained an Outperform rating and increased the price target from $121 to $130 on Dec. 19, 2023. This analyst has an accuracy rate of 82%.
  • Williams Trading analyst Sam Poser upgraded the stock from Sell to Hold and increased the price target from $91 to $92 on Sept. 29, 2023. This analyst has an accuracy rate of 73%.
  • BMO Capital analyst Simeon Siegel maintained an Outperform rating and cut the price target from $120 to $110 on Sept. 29, 2023. This analyst has an accuracy rate of 75%.
  • Morgan Stanley analyst Alex Kurtz reiterated an Overweight rating with a price target of $126 on Sept. 29, 2023. This analyst has an accuracy rate of 83%.
  • Barclays analyst Adrienne Yih maintained an Overweight rating and cut the price target from $124 to $119 on Sept. 29, 2023. This analyst has an accuracy rate of 70%.
Read This Next: Top 4 Health Care Stocks That May Crash This Month

Latest Ratings for NKE

DateFirmActionFromTo
Mar 2022Cowen & Co.MaintainsOutperform
Jan 2022Wells FargoUpgradesEqual-WeightOverweight
Jan 2022Seaport GlobalInitiates Coverage OnBuy
View More Analyst Ratings for NKE

View the Latest Analyst Ratings

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.